Abstract:Background—
Lysosomal carboxypeptidase, cathepsin A (protective protein, CathA), is a component of the lysosomal multienzyme complex along with β-galactosidase (GAL) and sialidase Neu1, where it activates Neu1 and protects GAL and Neu1 against the rapid proteolytic degradation. On the cell surface, CathA, Neu1, and the enzymatically inactive splice variant of GAL form the elastin-binding protein complex. In humans, genetic defects of CathA cause galactosialidosis, a metabolic disease c… Show more
“…27 Because increased proteolytic activity of cell-surface-delivered PPCA in transfected cells could potentially inactivate other mitogenic polypeptides (eg, endothelin-1 or angiotensin II), 83,84 results obtained from such an experimental model might not be conclusive. However, we demonstrated that treatment of cultured human AoSMCs with blocking antibody raised to human Neu 1 22 or with the competitive sialidase inhibitor ddNANA, which inhibits the activity of Neu1, 27 induced a significant up-regulation in their proliferation in response to fetal bovine serum.…”
We recently established that the elastin-binding protein, which is identical to the spliced variant of -galactosidase, forms a cell surface-targeted complex with two proteins considered "classic lysosomal enzymes": protective protein/cathepsin A and neuraminidase-1 (Neu1). We also found that cell surface-residing Neu1 can desialylate neighboring microfibrillar glycoproteins and facilitate the deposition of insoluble elastin, which contributes to the maintenance of cellular quiescence. Here we provide evidence that cell surfaceresiding Neu1 contributes to a novel mechanism that limits cellular proliferation by desialylating cell membrane-residing sialoglycoproteins that directly propagate mitogenic signals. We demonstrated that treatment of cultured human aortic smooth muscle cells (SMCs) with either a sialidase inhibitor or an antibody that blocks Neu1 activity induced significant up-regulation in SMC proliferation in response to fetal bovine serum. Conversely, treatment with Clostridium perfringens neuraminidase (which is highly homologous to Neu1) decreased SMC proliferation, even in cultures that did not deposit elastin. Further, we found that pretreatment of aortic SMCs with exogenous neuraminidase abolished their mitogenic responses to recombinant platelet-derived growth factor (PDGF)-BB and insulin-like growth factor (IGF)-2 and that sialidosis fibroblasts (which are exclusively deficient in Neu1) were more responsive to PDGF-BB and IGF-2 compared with normal fibroblasts. Furthermore , we provide direct evidence that neuraminidase caused the desialylation of both PDGF and IGF-1 receptors and diminished the intracellular signals induced by the mitogenic ligands
“…27 Because increased proteolytic activity of cell-surface-delivered PPCA in transfected cells could potentially inactivate other mitogenic polypeptides (eg, endothelin-1 or angiotensin II), 83,84 results obtained from such an experimental model might not be conclusive. However, we demonstrated that treatment of cultured human AoSMCs with blocking antibody raised to human Neu 1 22 or with the competitive sialidase inhibitor ddNANA, which inhibits the activity of Neu1, 27 induced a significant up-regulation in their proliferation in response to fetal bovine serum.…”
We recently established that the elastin-binding protein, which is identical to the spliced variant of -galactosidase, forms a cell surface-targeted complex with two proteins considered "classic lysosomal enzymes": protective protein/cathepsin A and neuraminidase-1 (Neu1). We also found that cell surface-residing Neu1 can desialylate neighboring microfibrillar glycoproteins and facilitate the deposition of insoluble elastin, which contributes to the maintenance of cellular quiescence. Here we provide evidence that cell surfaceresiding Neu1 contributes to a novel mechanism that limits cellular proliferation by desialylating cell membrane-residing sialoglycoproteins that directly propagate mitogenic signals. We demonstrated that treatment of cultured human aortic smooth muscle cells (SMCs) with either a sialidase inhibitor or an antibody that blocks Neu1 activity induced significant up-regulation in SMC proliferation in response to fetal bovine serum. Conversely, treatment with Clostridium perfringens neuraminidase (which is highly homologous to Neu1) decreased SMC proliferation, even in cultures that did not deposit elastin. Further, we found that pretreatment of aortic SMCs with exogenous neuraminidase abolished their mitogenic responses to recombinant platelet-derived growth factor (PDGF)-BB and insulin-like growth factor (IGF)-2 and that sialidosis fibroblasts (which are exclusively deficient in Neu1) were more responsive to PDGF-BB and IGF-2 compared with normal fibroblasts. Furthermore , we provide direct evidence that neuraminidase caused the desialylation of both PDGF and IGF-1 receptors and diminished the intracellular signals induced by the mitogenic ligands
“…In particular, the components of the multienzyme complex, Neu1, CathA, and -galactosidase (or its alternatively spliced elastin-binding form), participate in processing of endothelin-1 (21,33), assembly of the elastic fibers (21,34,35), pro-inflammatory response in macrophages (36), migration, invasion, and adhesion of cancer cells (37), proliferation of aortic smooth muscle cells (38), and exocytosis (39). In humans, genetic defects in CathA cause disruption of the complex and trigger galactosialidosis (MIM 256540), a severe multisystemic disease characterized by combined deficiency of Neu1, -galactosidase, and CathA (for review, see Ref.…”
Section: Discussionmentioning
confidence: 99%
“…Animals-CathA S190A mice carrying the point c.571AGCϾGCA (S190A) mutation in the CathA gene and CathA S190A-Neo mice carrying, in addition, a PGK-Neo cassette in intron 7 were generated through the targeted disruption of the CathA gene as described (21). The CathA S190A-Neo and CathA S190A mice ranging from 4 to 12 weeks of age were compared with the appropriate wild-type (WT) littermate controls.…”
Section: Methodsmentioning
confidence: 99%
“…To determine protein loading, the blot was stained with Ponceau S (Sigma). (21). In the first strain (CathA S190A ) we replaced the nucleophil of the CathA active site, Ser 190 , with Ala, which abolished the enzymatic activity, whereas the mutant protein retained its ability to activate Neu1.…”
Section: Lectin Fluorescence Microscopy and Lectin Blot Of Fc␥r-mentioning
confidence: 99%
“…To clarify the physiological role of Neu1 and CathA in the antigen-presenting immune cells, we have compared essential functional properties of macrophages (MØ) and immature dendritic cells (DC) from the genetically targeted mice having either a single CathA or a double CathA/Neu1 deficiency (21). The obtained data suggest that the cell surface Neu1 activates the phagocytosis in MØ and DC presumably through desialylation of multiple receptors, including Fc receptors for immunoglobulin G (Fc␥R).…”
The differentiation of monocytes into macrophages and dendritic cells is accompanied by induction of cell-surface neuraminidase 1 (Neu1) and cathepsin A (CathA), the latter forming a complex with and activating Neu1. To clarify the biological importance of this phenomenon we have developed the gene-targeted mouse models of a CathA deficiency (CathA S190A ) and a double CathA/Neu1 deficiency (CathA S190A-Neo ). Macrophages of CathA S190A-Neo mice and their immature dendritic cells showed a significantly reduced capacity to engulf Grampositive and Gram-negative bacteria and positively and negatively charged polymer beads as well as IgG-opsonized beads and erythrocytes. Properties of the cells derived from CathA S190A mice were indistinguishable from those of wild-type controls, suggesting that the absence of Neu1, which results in the increased sialylation of the cell surface proteins, probably affects multiple receptors for phagocytosis. Previous data showed that mammalian neuraminidase 1 (Neu1), 5 in addition to its role in the intralysosomal catabolism, may be also involved in cellular signaling during the immune response. In particular, during the activation of mouse T cells, Neu1 is expressed on the plasma membrane and is required for the early production of interleukin-4 and for the interaction of T cells with the antigen-presenting cells (8 -12). In addition, Neu1 of T cells converts the group-specific component (Gc protein) into a factor necessary for the inflammation-primed activation of macrophages (13,14). T cells derived from SM/J or B10.SM strains of mice with the reduced Neu1 activity, due to a missense mutation in the Neu1 gene (15), fail to convert Gc and synthesize interleukin-4, whereas B cells of these mice cannot produce IgG 1 and IgE after immunization with pertussis toxin (8,14,16). Strikingly, surface desialylation of macrophages by viral sialidase from Arthrobacter ureafaciens significantly increases their capacity for phagocytosis of influenza virus-infected HeLa cells (17), providing the direct link between the surface sialylation of antigen-presenting cells and their biological activity.Previously we showed that Neu1 increased 14-fold during the differentiation of human monocytes into macrophages (18).
* This work was supported in part by Canadian Institutes of Health ResearchOperating Grants MOP 15079 and GOP 38107 and by an equipment grant from Canadian Foundation for Innovation (to A. V. P.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.